The average cost of treatment according to lung cancer stage using real-world data by Pedro Aguiar Junior, Pedro De-Marchi, Rafael Paes, Isabella Favato, Gabriela Monte, Tatiane Montella, Filipe Visani, Nathalia Afonso, Izabella Negreiros, Rodrigo Dienstmann, Carlos Gil Ferreira

Get full text

Efficacy of osimertinib in advanced T790M-positive NSCLC after progression to prior EGFR-TKI: real world data from a Brazilian cohort by Luiz Henrique Araujo, Gilberto de Castro, Clarissa Baldotto, Marcelo Graziano Custódio, Pedro De-Marchi, Aknar Calabrich, Clarissa Mathias, André Santa-Maria, Maíra Takemoto, Helano Freitas

Get full text

Optimizing muscle mass and function in advanced lung cancer patients: randomized, double-blind, placebo-controlled trial protocol using High Eicosapentaenoic acid and PROtein (HEPR... by Imanuely Borchardt, Carla Prado, Tatiane Montella, Gisele Fraga Moreira, Gisele Farias, Marina Xavier Reis, Fernanda Taveira, Fernanda Carneiro Dias, Pedro De Marchi, Alberto Davalos, Carolina Alves Costa Silva, Carlos GilMoreira Ferreira, Andreia Melo, Wilza Peres

Get full text

Real-World Study on Implementation of Genomic Tests for Advanced Lung Adenocarcinoma in Brazil by Rodrigo Dienstmann, Leonard M. da Silva, Fernanda Orpinelli Ramos do Rego, Amanda Muniz Rodrigues, Fernanda Christtanini Koyama, Layla Testa Galindo, Carolina de Bustamante Fernandes, Bruno Batista de Souza, Rafael Duarte Paes, Tatiane Montella, Pedro de Marchi, Breno Jeha Araújo, Bruno Lemos Ferrari, Clarissa Mathias, Emilio Pereira, Mariano Gustavo Zalis, Chesley Leslin, Carlos Gil Ferreira

Get full text